Looking Backward, Looking Forward
I believe it is fair to say that 2016 was a bit unusual. Thinking about the terminology many of us learned last year leads us to that conclusion: snowflake,…
Menu
The Life Sciences in Wyoming – Part Two of Three
There's more to Wyoming than this. In Part One of his series, Dr. Garrett Lindemann discussed some of the challenges facing Wyoming as it grows its life science industry. In Part…
Insourcing: A new outsourcing approach?
Pharmaceutical outsourcing to CROs is certainly nothing new. However, this week we learned that pharmaceutical giant Lilly and AMRI signed an interesting insourcing / outsourcing agreement. In this deal, AMRI…
The SmartCells Story
Bruce Booth from Atlas Ventures has a fascinating story on his blog. We won't steal Bruce's thunder. Instead, we encourage you to read it there first. The gist of the story is…
The Era of the One Man Pharma Band (With Updates)
There is a fascinating discussion taking place over at Derek Lowe's blog today on one-man drug companies: ...some of them are not quite down to one person, but you can…
Carpe diem: What mergers can do for you
This is a fantastic piece in Nature by Anu Acharya, CEO of Ocimum Biosolutions in India. I recommend reading the article in full. A few key points that struck us…
Pfizer bypassing wholesalers in Oz
There is fascinating news today from Pfizer, who have decided to bypass the wholesalers in Australia and market directly to community pharmacies. To quote, "In order to develop stronger partnerships with…
Latin America – The Next Outsourcing Hotspot?
It's certainly interesting to consider Latin American countries from a US perspective. Aside from the friendlier time differences, transportation and logistics could be simpler, as the article suggests. From a…